Roche

News

FDA clears Roche digital pathology platform for diagnosis

Roche’s move into the digital pathology category has been boosted by FDA approval of a lab instrument and toolkit for use as an aid to clinical diagnosis.

News

FDA widens label for BMS’ cancer drug Augtyro

Bristol-Myers Squibb has claimed FDA approval for a new, tumour-agnostic indication for Augtyro, the cancer drug it acquired as part of its $4.1 billion takeover of Turning Point Therapeuti

News

Future of Pfizer’s Duchenne gene therapy in doubt

Pfizer is “evaluating appropriate next steps” for its Duchenne muscular dystrophy (DMD) gene therapy after it failed a phase 3 trial.

News

ALZpath licenses Alzheimer’s diagnosis tech to Roche

Diagnostics giant Roche is putting its weight behind a biomarker for Alzheimer’s disease developed by ALZpath.

News

Italy starts probe into Lucentis biosimilar delay allegation

Italy’s antitrust authority has launched an investigation against eight pharma companies, including Novartis and Roche, over suspicion they may have colluded to delay the

News

First patient gets bowel cancer jab in NHS 'matchmaker' push

The first patient has received a personalised colorectal cancer vaccine, produced by BioNTech, as part of NHS England and Genomics England’s Cancer Vaccine Launch Pad (CVL

FDA clears Roche digital pathology platform for diagnosis

FDA widens label for BMS’ cancer drug Augtyro

Future of Pfizer’s Duchenne gene therapy in doubt

ALZpath licenses Alzheimer’s diagnosis tech to Roche

Italy starts probe into Lucentis biosimilar delay allegation

First patient gets bowel cancer jab in NHS 'matchmaker' push

Consolidating data strategy for global success: Insights fro...

How to meet your physicians where they are online

Roche

Editor's Picks